Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(38%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
63%
Ph phase_3
1
13%
Ph phase_4
2
25%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(4)

Detailed Status

Completed4
Recruiting3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (12.5%)
Phase 42 (25.0%)
N/A5 (62.5%)

Trials by Status

completed450%
recruiting338%
not_yet_recruiting113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8